These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34528584)

  • 1. [Pulmonary artery denervation in pulmonary hypertension: physiological and clinical aspects].
    Evlakhov VI; Poiasov IZ; Ovsiannikov VI
    Angiol Sosud Khir; 2021; 27(3):16-21. PubMed ID: 34528584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial Effects of Renal Denervation on Pulmonary Vascular Remodeling in Experimental Pulmonary Artery Hypertension.
    Qingyan Z; Xuejun J; Yanhong T; Zixuan D; Xiaozhan W; Xule W; Zongwen G; Wei H; Shengbo Y; Congxin H
    Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):562-70. PubMed ID: 25804321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of renal denervation on monocrotaline induced pulmonary remodeling.
    Liu Q; Song J; Lu D; Geng J; Jiang Z; Wang K; Zhang B; Shan Q
    Oncotarget; 2017 Jul; 8(29):46846-46855. PubMed ID: 28187460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transthoracic Pulmonary Artery Denervation for Pulmonary Arterial Hypertension.
    Huang Y; Liu YW; Pan HZ; Zhang XL; Li J; Xiang L; Meng J; Wang PH; Yang J; Jing ZC; Zhang H
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):704-718. PubMed ID: 30816802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary artery denervation reduces pulmonary artery pressure and induces histological changes in an acute porcine model of pulmonary hypertension.
    Rothman AM; Arnold ND; Chang W; Watson O; Swift AJ; Condliffe R; Elliot CA; Kiely DG; Suvarna SK; Gunn J; Lawrie A
    Circ Cardiovasc Interv; 2015 Nov; 8(11):e002569. PubMed ID: 26553697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sympathetic innervation of canine pulmonary artery and morphometric and functional analysis in dehydromonocrotaline-induced models after pulmonary artery denervation.
    Jiang X; Zhang J; Zhou L; Luo J; Wang J; Li L; Chen S
    Interact Cardiovasc Thorac Surg; 2020 Nov; 31(5):708-717. PubMed ID: 33057705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone system.
    Liu C; Jiang XM; Zhang J; Li B; Li J; Xie DJ; Hu ZY
    BMC Cardiovasc Disord; 2016 Oct; 16(1):192. PubMed ID: 27724864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
    Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
    Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
    J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icotinib Attenuates Monocrotaline-Induced Pulmonary Hypertension by Preventing Pulmonary Arterial Smooth Muscle Cell Dysfunction.
    Peng LY; Yu M; Yang MX; Liu P; Zhou H; Huang W; Kong H; Xie WP
    Am J Hypertens; 2020 Aug; 33(8):775-783. PubMed ID: 32301965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary artery denervation significantly improves right ventricular longitudinal strain in pulmonary hypertension induced by dehydromonocrotaline.
    Dong J; Jiang XM; Zhang J; Xie DJ; Luo J; Ran H; Li L; Li M; Zhou L; Zhang PY
    Minerva Med; 2024 Feb; 115(1):119-120. PubMed ID: 35785955
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary artery denervation using catheter-based ultrasonic energy.
    Rothman A; Jonas M; Castel D; Tzafriri AR; Traxler H; Shav D; Leon MB; Ben-Yehuda O; Rubin L
    EuroIntervention; 2019 Oct; 15(8):722-730. PubMed ID: 31062694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of asymmetric dimethylarginine and Rho kinase in the vascular remodeling in monocrotaline-induced pulmonary hypertension.
    Li XH; Peng J; Tan N; Wu WH; Li TT; Shi RZ; Li YJ
    Vascul Pharmacol; 2010; 53(5-6):223-9. PubMed ID: 20840872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension).
    Chen SL; Zhang FF; Xu J; Xie DJ; Zhou L; Nguyen T; Stone GW
    J Am Coll Cardiol; 2013 Sep; 62(12):1092-1100. PubMed ID: 23850902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
    Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary Artery Denervation: Update on Clinical Studies.
    Zhang H; Chen SL
    Curr Cardiol Rep; 2019 Sep; 21(10):124. PubMed ID: 31486924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction.
    Baber SR; Deng W; Master RG; Bunnell BA; Taylor BK; Murthy SN; Hyman AL; Kadowitz PJ
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1120-8. PubMed ID: 16980338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Artery Hypertension Model in Rats by Monocrotaline Administration.
    Bueno-Beti C; Sassi Y; Hajjar RJ; Hadri L
    Methods Mol Biol; 2018; 1816():233-241. PubMed ID: 29987824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response.
    Yang JM; Zhou R; Zhang M; Tan HR; Yu JQ
    Molecules; 2018 May; 23(6):. PubMed ID: 29861433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.